Compounds > n-acetylneuraminic acid

n-acetylneuraminic acid and Malignant Mesothelioma

n-acetylneuraminic acid has been researched along with Malignant Mesothelioma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Hosono, M; Nakasato, A; Sugawara, S; Tatsuta, T1
Imai, K; Kaji, H; Matsuura, R; Misawa, H; Moriwaki, Y; Narimatsu, H; Sato, T; Tomioka, A; Tsuji, S1

Other Studies

2 other study(ies) available for n-acetylneuraminic acid and Malignant Mesothelioma

ArticleYear
Transcriptomic alterations in malignant pleural mesothelioma cells in response to long‑term treatment with bullfrog sialic acid‑binding lectin.
    Molecular medicine reports, 2021, Volume: 23, Issue:6

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Lectins; Mesothelioma; Mesothelioma, Malignant; N-Acetylneuraminic Acid; Prognosis; Rana catesbeiana; Transcriptome

2021
Identification of mesothelioma-specific sialylated epitope recognized with monoclonal antibody SKM9-2 in a mucin-like membrane protein HEG1.
    Scientific reports, 2018, 09-24, Volume: 8, Issue:1

    Topics: Antibodies, Monoclonal; Cell Line, Tumor; Enzyme-Linked Immunosorbent Assay; Epitopes; Glycosylation; Humans; Lectins; Lung Neoplasms; Mass Spectrometry; Membrane Proteins; Mesothelioma; Mesothelioma, Malignant; N-Acetylneuraminic Acid; Peptides; Polysaccharides; Protein Binding

2018